Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

Locana Raises $55M Series A Financing To Advance Portfolio Of Rna-targeting Gene Therapies

by vcaonline.com posted 1month ago 17 views
Jeffrey M. Ostrove, Ph.D. named chief executive officer Proprietary technology based on pioneering work from the lab of Eugene (Gene) Yeo, Ph.D. of UC San Diego SAN DIEGO, May 22, 2019-- Locana, Inc., a leading RNA-targeting gene therapy company, announced today the close of a $55 million Series A financing led by ARCH Venture Partners with participation from Temasek and Lightstone Ventures, all existing investors. New investors include UCB Ventures and GV (formerly Google Ventures).

In this article